Gregory Jewell, MD
Obstetrics & Gynecology · Saint Louis, MONPI 1104861756
Payments from drug & device makers
Across 138 payments — averaging $41.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Duchesnay USA Incorporated$3K
- Amgen$422
- Astellas Pharma US Inc$378
- AbbVie$220
- Sumitomo Pharma America, Inc.$161
- Mayne Pharma Commercial LLC$150
- plus $1K from 22 others
What the payments were for
- Speaking & faculty fees$3,00053%
- Travel & lodging$401%
- Food & beverage$2,46443%
- Education$1893%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Duchesnay USA Incorporated | 6 | $3,178 |
| Amgen | 17 | $422 |
| Astellas Pharma US Inc | 15 | $378 |
| AbbVie | 18 | $220 |
| Sumitomo Pharma America, Inc. | 7 | $161 |
| Mayne Pharma Commercial LLC | 10 | $150 |
| Exeltis, USA Inc. | 5 | $89 |
| Novo Nordisk | 5 | $89 |
| Evofem Biosciences, Inc. | 5 | $88 |
| Hologic Sales And Service, LLC | 4 | $86 |
| Radius Health, Inc. | 4 | $80 |
| Pfizer | 6 | $76 |
| Johnson & Johnson | 2 | $74 |
| Millicent US Inc | 4 | $70 |
| Myovant Sciences Inc. | 4 | $70 |
| Lupin Inc. | 4 | $58 |
| Avion Pharmaceuticals | 3 | $52 |
| Myriad Women's Health, Inc. | 1 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $51 |
| Therapeuticsmd, Inc. | 3 | $43 |
| Meditrina | 3 | $42 |
| Medtronic | 2 | $34 |
| Bayer | 2 | $28 |
| Aspira Women's Health Inc | 2 | $28 |
| Sage Therapeutics, LLC | 1 | $22 |
| Aesculap, Inc. | 1 | $18 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,693 in reported general payments places this provider in the 90th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TymlosAbaloparatide | 77 | $215,009 |
| Teriparatide | 40 | $130,785 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 22 | $56,607 |
| Risedronate Sodium | 166 | $19,662 |
| MyrbetriqMirabegron | 14 | $10,349 |
| Raloxifene Hcl | 159 | $6,066 |
| Ibandronate Sodium | 155 | $4,086 |
| Estradiol | 81 | $2,538 |
| Alendronate Sodium | 300 | $2,081 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 16 | $855 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 19 | $784 |
| Escitalopram Oxalate | 11 | $148 |
| Hydrocortisone | 15 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Radius Health, Inc.Tymlos | $80 | $215,00977 claims |
| AmgenEvenity (2 Syringes) | $422 | $56,60722 claims |
| Astellas Pharma US IncMyrbetriq | $378 | $10,34914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 750 obstetrics & gynecology providers in Missouri.
Other obstetrics & gynecology in Saint Louis
- Becky LynnSaint Louis$231K
- Makeba WilliamsSaint Louis$48K
- Kimberly LemoineSaint Louis$30K
- David WeinsteinSaint Louis$25K
- Haifaa YounisSaint Louis$22K
- David KrausSaint Louis$16K
- Kaci DurbinSaint Louis$14K
- Wendi CarnsSaint Louis$14K
- Melissa TepeSaint Louis$11K
- Jill ScherbelSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.